Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U9GZ
|
|||
| Former ID |
DIB016594
|
|||
| Drug Name |
Recombinant protein subunit vaccine, Emergent
|
|||
| Synonyms |
TracVax; Chlamydia trachomatis vaccine, Antex; Chlamydia trachomatis vaccine, BioPort; Chlamydia trachomatis vaccine, Emergent; Recombinant protein subunit vaccine (injectable, Chlamydia trachomatis); Recombinant protein subunit vaccine (injectable, Chlamydia trachomatis), Emergent
Click to Show/Hide
|
|||
| Indication | Infectious disease [ICD-11: 1A00-CA43.1; ICD-9: 001-139] | Preclinical | [1] | |
| Company |
BioPort Corporation
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007158) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.